A non-conserved histidine residue on KRAS drives paralog selectivity of the KRAS G12D inhibitor MRTX1133
M. A. Keats, J. J. W. Han, Y.-H. Lee, C.-S. Lee, J. Luo
This study identifies histidine 95 as a key determinant of KRAS selectivity for the inhibitor MRTX1133, showing it binds specifically to KRAS but not HRAS or NRAS.
bioRxiv · Dec 16, 2022 · PreprintCancer Biology